Pulmonary Embolism clinical trials
28 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
- Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
- The PERSEVERE Study
- Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism
- Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)
- Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness
- Apixaban in Thrombocytopenia
- Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
- Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
- Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
- The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
- Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
- Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
- Registry of Patients Prescribed Anticoagulation
- Pulmonary Embolism and Right-to-Left Shunts
- Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
- Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
- Aspiration Thrombectomy Using the Symphony or Prodigy System
- A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
- Supplemental Oxygen in Pulmonary Embolism (SO-PE)
- Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)
- Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study
- Nudging Provider Adoption of Clinical Decision Support: Implementation of an EHR-Agnostic Pulmonary Embolism Risk Prediction Tool
- Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty
- The PEERLESS II Study
- Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Pulmonary Embolism” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.